(CAL) Caleres - Overview
Stock: Footwear, Athletic, Casual, Dress, Wholesale, Retail
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.92% |
| Yield on Cost 5y | 1.85% |
| Yield CAGR 5y | 0.00% |
| Payout Consistency | 93.2% |
| Payout Ratio | 21.9% |
| Risk 5d forecast | |
|---|---|
| Volatility | 64.1% |
| Relative Tail Risk | -9.67% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.15 |
| Alpha | -47.53 |
| Character TTM | |
|---|---|
| Beta | 1.574 |
| Beta Downside | 1.147 |
| Drawdowns 3y | |
|---|---|
| Max DD | 77.68% |
| CAGR/Max DD | -0.22 |
Description: CAL Caleres December 28, 2025
Caleres, Inc. (NYSE: CAL) designs, sources, manufactures, and distributes a broad portfolio of footwear across the United States, Canada, East Asia, and other international markets. The business operates through two primary segments-Famous Footwear (a large-format discount retailer) and Brand Portfolio (which includes owned and licensed brands such as Sam Edelman, Allen Edmonds, and Naturalizer)-and sells both through its own brick-and-mortar stores, wholesale partners, and a suite of e-commerce sites.
Key recent metrics (FY 2023) show total revenue of roughly **$5.2 billion**, with **e-commerce accounting for about 22 % of net sales**, a rate that has risen ~4 percentage points year-over-year. Comparable-store sales in the Famous Footwear segment grew **+3.5 %**, driven largely by strong demand for casual and athleisure styles, while the Brand Portfolio segment posted a **+5 %** increase in wholesale volume as retailers replenish inventory after pandemic-induced shortages.
The footwear sector is currently sensitive to **consumer discretionary spending trends**, which are in turn influenced by real-wage growth and confidence indices. Additionally, **supply-chain resiliency-particularly the ability to source leather and synthetic materials at stable costs-remains a material driver of margins**, given recent volatility in commodity prices and freight rates.
For a data-rich, quantitative deep-dive on CAL’s valuation and risk factors, the ValueRay platform offers a dedicated dashboard worth exploring.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: 20.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.00 > 0.02 and ΔFCF/TA -3.03 > 1.0 |
| NWC/Revenue: 2.10% < 20% (prev 2.30%; Δ -0.20% < -1%) |
| CFO/TA 0.05 > 3% & CFO 107.9m > Net Income 20.6m |
| Net Debt (446.0m) to EBITDA (84.0m): 5.31 < 3 |
| Current Ratio: 1.06 > 1.5 & < 3 |
| Outstanding Shares: last quarter (32.6m) vs 12m ago -2.67% < -2% |
| Gross Margin: 43.28% > 18% (prev 0.45%; Δ 4284 % > 0.5%) |
| Asset Turnover: 133.9% > 50% (prev 142.2%; Δ -8.23% > 0%) |
| Interest Coverage Ratio: 1.55 > 6 (EBITDA TTM 84.0m / Interest Expense TTM 17.7m) |
Altman Z'' 1.27
| A: 0.03 (Total Current Assets 981.0m - Total Current Liabilities 924.3m) / Total Assets 2.08b |
| B: 0.21 (Retained Earnings 446.3m / Total Assets 2.08b) |
| C: 0.01 (EBIT TTM 27.5m / Avg Total Assets 2.02b) |
| D: 0.29 (Book Value of Equity 420.0m / Total Liabilities 1.45b) |
| Altman-Z'' Score: 1.27 = BB |
Beneish M -3.01
| DSRI: 1.06 (Receivables 180.8m/176.1m, Revenue 2.70b/2.78b) |
| GMI: 1.04 (GM 43.28% / 44.90%) |
| AQI: 1.00 (AQ_t 0.24 / AQ_t-1 0.25) |
| SGI: 0.97 (Revenue 2.70b / 2.78b) |
| TATA: -0.04 (NI 20.6m - CFO 107.9m) / TA 2.08b) |
| Beneish M-Score: -3.01 (Cap -4..+1) = AA |
What is the price of CAL shares?
Over the past week, the price has changed by +6.22%, over one month by -0.76%, over three months by +18.20% and over the past year by -23.26%.
Is CAL a buy, sell or hold?
- StrongBuy: 1
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the CAL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 17 | 31% |
| Analysts Target Price | 17 | 31% |
| ValueRay Target Price | 12.5 | -3.5% |
CAL Fundamental Data Overview February 04, 2026
P/E Forward = 6.9061
P/S = 0.1592
P/B = 0.6716
P/EG = 0.74
Revenue TTM = 2.70b USD
EBIT TTM = 27.5m USD
EBITDA TTM = 84.0m USD
Long Term Debt = 606.1m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 355.0m USD (from shortTermDebt, last quarter)
Debt = 480.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 446.0m USD (from netDebt column, last quarter)
Enterprise Value = 876.1m USD (430.1m + Debt 480.0m - CCE 34.0m)
Interest Coverage Ratio = 1.55 (Ebit TTM 27.5m / Interest Expense TTM 17.7m)
EV/FCF = 117.3x (Enterprise Value 876.1m / FCF TTM 7.47m)
FCF Yield = 0.85% (FCF TTM 7.47m / Enterprise Value 876.1m)
FCF Margin = 0.28% (FCF TTM 7.47m / Revenue TTM 2.70b)
Net Margin = 0.76% (Net Income TTM 20.6m / Revenue TTM 2.70b)
Gross Margin = 43.28% ((Revenue TTM 2.70b - Cost of Revenue TTM 1.53b) / Revenue TTM)
Gross Margin QoQ = 41.76% (prev 43.40%)
Tobins Q-Ratio = 0.42 (Enterprise Value 876.1m / Total Assets 2.08b)
Interest Expense / Debt = 1.14% (Interest Expense 5.50m / Debt 480.0m)
Taxrate = 21.50% (29.1m / 135.2m)
NOPAT = 21.6m (EBIT 27.5m * (1 - 21.50%))
Current Ratio = 1.06 (Total Current Assets 981.0m / Total Current Liabilities 924.3m)
Debt / Equity = 0.78 (Debt 480.0m / totalStockholderEquity, last quarter 616.8m)
Debt / EBITDA = 5.31 (Net Debt 446.0m / EBITDA 84.0m)
Debt / FCF = 59.71 (Net Debt 446.0m / FCF TTM 7.47m)
Total Stockholder Equity = 608.6m (last 4 quarters mean from totalStockholderEquity)
RoA = 1.02% (Net Income 20.6m / Total Assets 2.08b)
RoE = 3.39% (Net Income TTM 20.6m / Total Stockholder Equity 608.6m)
RoCE = 2.26% (EBIT 27.5m / Capital Employed (Equity 608.6m + L.T.Debt 606.1m))
RoIC = 2.36% (NOPAT 21.6m / Invested Capital 913.7m)
WACC = 6.01% (E(430.1m)/V(910.1m) * Re(11.72%) + D(480.0m)/V(910.1m) * Rd(1.14%) * (1-Tc(0.22)))
Discount Rate = 11.72% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.92%
[DCF Debug] Terminal Value 80.20% ; FCFF base≈31.0m ; Y1≈20.3m ; Y5≈9.28m
Fair Price DCF = N/A (negative equity: EV 285.6m - Net Debt 446.0m = -160.4m; debt exceeds intrinsic value)
EPS Correlation: -80.42 | EPS CAGR: -52.39% | SUE: -1.47 | # QB: 0
Revenue Correlation: -26.82 | Revenue CAGR: 4.11% | SUE: 1.57 | # QB: 1
EPS next Quarter (2026-04-30): EPS=0.28 | Chg30d=+0.000 | Revisions Net=+1 | Analysts=1
EPS next Year (2027-01-31): EPS=1.67 | Chg30d=+0.000 | Revisions Net=-3 | Growth EPS=+203.6% | Growth Revenue=+5.7%